Personal genomics firm 23andMe has laid off an undisclosed number of employees as part of its workforce restructuring efforts, the company said in a statement. "These cuts, which are a reflection of the current economic environment all companies are facing, will allow us to continue to invest in the growth of our Personal Genome Service and research endeavors."

Related Summaries